BioSpace News Archive

AnaptysBio is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics.

At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. We create the world’s most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes.

At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes.

Global Blood Therapeutics was acquired by Pfizer in August 2022.

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step.

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.

BlackThorn Therapeutics was acquired by Neumora Therapeutics in 2020.

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.